Cipaglucosidase plus miglustat vs alglucosidase alfa plus placeboQoL · adults with LOPD1 finding from 1 reviewEnzyme replacement therapy for late‐onset Pompe disease 2023 · Cochrane Headline outcomes onlyno estimate extracted1 study · 121 participantsLow